Abstract:Drug resistance is a key impediment to cancer treatment, however, the resistance mechanism remains controversial. Experiment evidence indicated that persister cells, a subpopulation in a transient pseudo-dormant state, are posited to play a potential role in the emergence of resistance. In this study, we propose a novel mathematical model for describing the interactions among sensitive, persister, and resistant cells to qualitatively and quantitatively analyze how persister cells affect cancer evolution and unravel the underlying resistance mechanisms. The proposed model is validated by theoretical analysis and fitting of actual human CT scan and mice data. Theoretical analysis demonstrates the existence and stability of the multiple steady states, as well as the global asymptotical stability of a unique steady state. Furthermore, bifurcation analysis reveals that the key factors, including the apoptotic rate of sensitive cells and the transformation rate between sensitive and persister cells, induce bistable phenomenon and are characterized by double saddle–node and transcritical bifurcations. The bistable region indicates that persister cells under high stable steady state as a reservoir could promote the emergence of resistant cells conferring a proliferative advantage and conversely when they are in lower stable steady state, the source of resistant cells and resistance process will be controlled. Therefore, the first transcritical bifurcation point can be viewed as an early indicator to detect critical transitions from low resistance to high resistance. Together, the proposed model and quantitative results would provide new insights for searching for strategies in modulating and decreasing the risk of drug resistance.

Mathematical modeling of combined therapies for treating tumor drug resistance

A mathematical model of tumor-immune interactions incorporated with danger model

Mathematical modeling and bifurcation analysis for a biological mechanism of cancer drug resistance

Mathematical Modeling and Analysis of Tumor Chemotherapy

Mathematical Modeling of Therapy-induced Cancer Drug Resistance: Connecting Cancer Mechanisms to Population Survival Rates

Mathematical modeling and dynamic analysis of anti-tumor immune response

Mathematical modeling and dynamic analysis for cancer resistance incorporating persister cells

Combination therapies and intra-tumoral competition: Insights from mathematical modeling

A Mathematical Model to Study the Effect of Drug Kinetics on the Drug-Induced Resistance in Tumor Growth Dynamics

Mathematical model of tumor immune microenvironment with application to the combined therapy targeting the PD-1/PD-L1 pathway and IL-10 cytokine antibody

Dynamics of a tumor-immune model considering targeted chemotherapy

A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach

In Silico Synergism and Antagonism of an Anti-Tumour System Intervened by Coupling Immunotherapy and Chemotherapy: a Mathematical Modelling Approach.

Mathematical Modeling of Tumor Immune Interactions: The Role of Anti-FGFR and Anti-PD-1 in the Combination Therapy

Mathematical modeling in scheduling cancer treatment with combination of VEGF inhibitor and chemotherapy drugs.

Prospect for application of mathematical models in combination cancer treatments

Stability of a Mathematical Model with Piecewise Constant Arguments for Tumor-Immune Interaction under Drug Therapy.

Modeling the dynamics of mixed immunotherapy and chemotherapy for the treatment of immunogenic tumor

Mathematical Modeling of the Synergetic Effect between Radiotherapy and Immunotherapy

The local and global dynamics of a cancer tumor growth and chemotherapy treatment model

Mathematical Modeling and Analysis of Tumor Growth in response to a Mixed Chemotherapy and Immune Checkpoint Inhibition Therapy